COVID-19 in chronic myeloid leukemia patients in Latin America

References

• Bogoch II, Watts A, Thomas-Bachli A, et al. Pneumonia of unknown aetiology in Wuhan, China: Potential for international spread via commercial air travel. J Travel Med. 2020;27(2):taaa008.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• WHO Coronavirus Disease (COVID-19) Dashboard. Data last updated: 2021/2/15. https://covid19.who.int/. 2021.
   Google Scholar
• Malta M, Murray L, da Silva CMFP, et al. Coronavirus in Brazil: The heavy weight of inequality and unsound leadership. EClinicalMedicine. 2020;25:100472.
   PubMedGoogle Scholar
• The Lancet. COVID-19 in Latin America: a humanitarian crisis [Internet]. Lancet. 2020;396(10261):1463.
   PubMed Web of Science ®Google Scholar
• Miller MJ, Loaiza JR, Takyar A, et al. Covid-19 in latin america: novel transmission dynamics for a global pandemic? PLoS Negl Trop Dis. 2020;14(5):e0008265.
   PubMed Web of Science ®Google Scholar
• Robilotti EV, Babady NE, Mead PA, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020;26(8):1218–1223.
   PubMed Web of Science ®Google Scholar
• Lee LYW, Cazier JB, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926.
   PubMed Web of Science ®Google Scholar
• Huang J, Lin H, Wu Y, et al. COVID-19 in posttransplant patients-report of 2 cases. Am J Transplant. 2020;20(7):1879–1881.
   PubMed Web of Science ®Google Scholar
• Abruzzese E, Luciano L, D'Agostino F, et al. SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection. Mediterr J Hematol Infect Dis. 2020;12(1):e2020031.
   PubMed Web of Science ®Google Scholar
• Sorà F, Chiusolo P, Laurenti L, et al. SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation. Transfus Apher Sci. 2020;59(6):102881.
   PubMed Web of Science ®Google Scholar
• Li W, Wang D, Guo J, et al.; Hubei Anti-Cancer Association. COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 2020;34(7):1799–1804.
   PubMed Web of Science ®Google Scholar
• Breccia M, Abruzzese E, Bocchia M, et al.; Campus CML working group. Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey. Leukemia [Internet]. 2020;34(8):2260–2261.
   PubMed Web of Science ®Google Scholar
• Ector GICG, Huijskens EGW, Blijlevens NMA, et al. Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study. Leukemia. 2020;34(9):2533–2535.
   PubMed Web of Science ®Google Scholar
• Başcı S, Ata N, Altuntaş F, et al.; Turkish Ministry of Health, Hematology Scientific Working Group. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020;26(7):1676–1682.
   PubMed Web of Science ®Google Scholar
• Rea D, Mauro MJ, Cortes JE, et al. COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): results from the international CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study. Blood. 2020;136(Supplement 1):46–47.
   Web of Science ®Google Scholar
• Cross NCP, White HE, Colomer D, et al. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia. 2015;29(5):999–1003.
   PubMed Web of Science ®Google Scholar
• Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34(4):966–984.
   PubMed Web of Science ®Google Scholar
• Yılmaz U, Pekmezci A, Gül Y, et al. COVID-19 in chronic-phase chronic myeloid leukemia patients: a single-center survey from Turkey. Turk J Haematol. 2021;38(1):79–81.
   PubMed Web of Science ®Google Scholar
• Pagnano KBB, Miranda EC, Delamain MT, et al. Influence of BCR-ABL transcript type on outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib. Clin Lymphoma Myeloma Leuk. 2017;17(11):728–733.
   PubMed Web of Science ®Google Scholar
• Pagnano KB, Fava C, Miranda EC, et al. Efficacy and safety of generic imatinib compared to glivec in chronic phase - chronic myeloid leukemia - a multicenter, observational study. Blood. 2018. 132:46–46.
   Google Scholar
• Morales-Chacón K, Bourlon C, Acosta-Medina AA, et al. Impact of additional cytogenetic abnormalities on the clinical behavior of patients with chronic myeloid leukemia: report on a latin american population. Clin Lymphoma Myeloma Leuk. 2019;19(6):e299–e306.
   PubMed Web of Science ®Google Scholar
• Höglund M, Sandin F, Simonsson B. Epidemiology of chronic myeloid leukaemia: an update. Ann Hematol. 2015;94(Suppl 2):S241–S247.
   PubMed Web of Science ®Google Scholar
• Chauvin JP, Fowler A, Herrera LN. The younger age profile of COVID-19 deaths in developing countries [Internet]. Washington (DC): Inter-American Development Bank, Felipe Herrera Library. 2020. Available from: https://publications.iadb.org/en/node/29388.
   Google Scholar
• Cattaneo C, Daffini R, Pagani C, et al. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19. Cancer. 2020;126(23):5069–5076.
   PubMed Web of Science ®Google Scholar
• Demeter J, Weisinger J, Nagy Z. Mild clinical course of COVID-19 infection in Chronic Myeloid Leukemia (CML) patients receiving Tyrosine Kinase Inhibitors (TKIs) without interruption. Mediterr J Hematol Infect Dis. 2021;13(1):e2021022.
   PubMed Web of Science ®Google Scholar
• Mounir L, Mehdi S, Kawtar F, et al. Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report. Pan Afr Med J. 2020;37:34.
   PubMed Web of Science ®Google Scholar
• Zhang L-L, Liu Y, Guo Y-G, et al. Convalescent plasma rescued a severe COVID-19 patient with chronic myeloid leukemia blast crisis and myelofibrosis. Turk J Haematol. 2021;18(1):74–76.
   PubMed Web of Science ®Google Scholar
• Sisk JM, Frieman MB, Machamer CE. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. J Gen Virol. 2018;99(5):619–630.
   PubMed Web of Science ®Google Scholar
• Thornton J. Covid-19: lack of testing in Brazil is a “major failure,” says MSF. BMJ [Internet]. 2020;370:m2659.
   Google Scholar